These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32716527)

  • 21. [
    Guo W; Chen Y; He X; Fu H; Huang J; Chen H
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2910-2911. PubMed ID: 36872390
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Wild D; Antwi K; Fani M; Christ ER
    J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study.
    Antwi K; Fani M; Nicolas G; Rottenburger C; Heye T; Reubi JC; Gloor B; Christ E; Wild D
    J Nucl Med; 2015 Jul; 56(7):1075-8. PubMed ID: 25999434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 68Ga-Exendin-4 PET/CT in Evaluation of Endoscopic Ultrasound-Guided Ethanol Ablation of an Insulinoma.
    Luo Y; Li J; Yang A; Yang H; Li F
    Clin Nucl Med; 2017 Apr; 42(4):310-311. PubMed ID: 28134698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
    Prasad V; Sainz-Esteban A; Arsenic R; Plöckinger U; Denecke T; Pape UF; Pascher A; Kühnen P; Pavel M; Blankenstein O
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1593-600. PubMed ID: 26923247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
    Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
    Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
    Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
    Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
    Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
    Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT.
    Antwi K; Nicolas G; Fani M; Christ E; Wild D
    Clin Nucl Med; 2019 May; 44(5):e347-e348. PubMed ID: 30889001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.
    Luo Y; Li N; Kiesewetter DO; Chen X; Li F
    Clin Nucl Med; 2016 Apr; 41(4):341-3. PubMed ID: 26647001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
    Antwi K; Fani M; Heye T; Nicolas G; Rottenburger C; Kaul F; Merkle E; Zech CJ; Boll D; Vogt DR; Gloor B; Christ E; Wild D
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2318-2327. PubMed ID: 30054698
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
    J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Li L; Zhao R; Hong H; Li G; Zhang Y; Luo Y; Zha Z; Zhu J; Qiao J; Zhu L; Kung HF
    Nucl Med Biol; 2021; 102-103():87-96. PubMed ID: 34695640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early
    Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
    Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
    Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Localization of Insulinomas Using
    Boss M; Eriksson O; Mikkola K; Eek A; Brom M; Buitinga M; Brouwers AH; Velikyan I; Waser B; Kauhanen S; Solin O; Marciniak C; Eriksson B; Reubi JC; Aveline C; Wild D; Pattou F; Talbot JN; Hofland J; Sundin A; Nuutila P; Hermans J; Gotthardt M
    J Nucl Med; 2024 Oct; ():. PubMed ID: 39419553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
    Christ E; Wild D; Ederer S; Béhé M; Nicolas G; Caplin ME; Brändle M; Clerici T; Fischli S; Stettler C; Ell PJ; Seufert J; Gloor B; Perren A; Reubi JC; Forrer F
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):115-22. PubMed ID: 24622317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive detection of insulinoma using [
    Murakami T; Fujimoto H; Hamamatsu K; Yamauchi Y; Kodama Y; Fujita N; Fujikura J; Shimizu Y; Nakamoto Y; Kimura H; Saji H; Inagaki N
    Sci Rep; 2021 Jul; 11(1):15014. PubMed ID: 34294854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT.
    Werner C; Lupp A; Drescher R; Freesmeyer M; Mireskandari M; Stoykow C; Bauschke A; Müller UA
    J Med Imaging Radiat Oncol; 2018 Jun; 62(3):370-374. PubMed ID: 29399966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.